Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

BATTALION
Battalion Oil Publishes Sept 2026 Investor Presentation

Battalion Oil updated its strategic priorities and operational progress in a new investor presentation. The release outlines guidance and balance-shee...

Sizzle
SPAC sets September 30 closing date

Sizzle Acquisition II and Trasteel have amended the business combination agreement to extend a deadline and modify the governance of the combined publ...

bioAffinity
bioAffinity launches federal CyPath Lung distribution partnership with AvMEDICAL

The company debuted its noninvasive lung cancer test at NAVREF 2026. This partnership expands federal access to the test and addresses a significant h...

POWERCOMPUTE,
PowerCompute Eliminates All Pledged Bitcoin

PowerCompute fully repaid its $22.45 million Bitcoin-backed facility, reducing secured debt by ~94%. Additionally, the company announced expansion pro...

Integer
Integer shares early termination of HSR for KKR agreement

Integer reported the completion of regulatory review for the $5.7 billion sale to KKR; the merger requires stockholder approval scheduled for October ...

Zcash
Zcash ETF Completes 3-for-1 Forward Split

The Zcash ETF (ZCSH) completed a 3-for-1 forward split effective September 30, 2026, without altering the total value of shareholder investments....

POWER
PSI Signs New Revolving Credit Agreement

Power Solutions International, Inc. entered into a new revolving credit agreement dated September 25, 2026, with HSBC as the administrative agent. The...

PITNEY
Pitney Bowes Credit Agreement Amendment

Pitney Bowes enters into a Fifth Amendment to its Credit Agreement to add a $585.49M 2026 Tranche B Term Loan facility and refinance outstanding loans...

ACM
ACM Shanghai posts 88.2% year-over-year backlog increase

ACM Research's subsidiary reported a total backlog of RMB 17.1 billion as of September 29, 2026, driven by strong demand for wafer and panel processin...

Celcuity
Celcuity announces US launch of FDA-approved breast cancer drug REVTORPYK

Celcuity Inc. announced that REVTORPYK (gedatolisib), an FDA-approved breast cancer therapy, is commercially available in the US. The launch follows r...

Iron
Electra AI signs new battery customers ahead of SPAC IPO

Electra AI announced new customers Mooving and Omega Seiki Mobility, and partnerships with D-Orbit and MinTech, ahead of its proposed merger with Iron...

Kardigan,
Kardigan Appoints Kristin Reinke to its Board of Directors

Kardigan, Inc. (Nasdaq: KARD) announced the appointment of Kristin Reinke as the new Chair of the Audit Committee and the stepping down of Doug Giorda...

Crypto
Crypto Co Announces Private Testnet Launch

Crypto Co live-tests their quantum-resistant Layer 1 blockchain, Frame, announcing 7 million test transactions processed in under two seconds....

AEON
AI Biopharma Receives FDA Development Feedback for BOTOX Biosimilar

AEON Biopharma received FDA encouragement for a streamlined development path for ABP-450, supporting a potentially more efficient clinical program and...

Hewlett
HPE raises Networking growth outlook for fiscal 2027

HPE updated its networking strategy to capture AI-driven demand, raising its fiscal 2027 revenue growth outlook and expecting to gain market share. Th...

GENERAL
General Mills names Dana McNabb as new CEO

General Mills announced Dana McNabb will succeed Jeff Harmening as CEO effective January 1, 2027. The move aims to drive profitable growth through dig...

JABIL
Jabil Beats Q4 Estimates and Sees FY27 Revenue Growth

Jabil Inc. reported fiscal 2026 results exceeding expectations with 21% revenue growth and $1.5B in adjusted free cash flow. The company provided an o...

Aperture
Atlantic HPC acquires 29 MW of power in Tennessee

Atlantic HPC has acquired Valley Oasis Development LLC, gaining contracted power for 29 MW in Dyersburg, Tennessee, expanding its grid-constrained foo...

CONAGRA
Conagra Brands Reports Q1 FY 2027 Sales And Earnings

Conagra Brands reported a 1.4% decrease in net sales to $2.6 billion and increased diluted EPS by 5.9% for Q1 FY 2027, while reaffirming its fiscal 20...

Rafael
Rafel announces Phase 3 Trappsol Cyclo failed primary endpoint but meets others

Rafael Holdings disclosed that Trappsol Cyclo failed its primary endpoint in a pivotal NPC study despite positive prespecified subgroup results, resul...